Steve Krognes

Mr. Steve E. Krognes is an Independent Director at Gritstone Oncology, Inc., an Independent Director at RLS Global AB, an Independent Director at Corvus Pharmaceuticals, Inc. and a Treasurer, Chief Financial & Accounting Officer at Denali Therapeutics, Inc. He is on the Board of Directors at Gritstone Oncology, Inc., RLS Global AB and Corvus Pharmaceuticals, Inc. Mr. Krognes was previously employed as a CFO, Senior VP, Regional Head-Finance & IT by Genentech, Inc., a Chairman by Genentech Access To Care Foundation, a Head-Mergers & Acquisitions by Roche Holding AG, and a Director-Mergers & Acquisitions by GiroBank A/S. He also served on the board at The California Academy of Sciences and California Life Sciences Association. He received his undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from Harvard Business School.